Burke Bioventures
Consultancy that provides strategic scientific advice and interim R&D management for life‑science organizations. Core work includes advisory support across discovery to early clinical development, technology due diligence for investors and deal processes, and operational interim management for venture-backed start-ups. Stated focus areas include nanotechnology, targeted delivery, and RNA.
Industries
Nr. of Employees
small (1-50)
Products
Strategic Advisory Services
Provides strategic advice and scientific direction for biopharma R&D from discovery to early clinical development stages.
Interim Management
Offers temporary operational and executive management support to supplement or lead R&D teams in biotech startups and companies.
Technology Diligence
Conducts technical due diligence to support venture investment, licensing, and mergers and acquisitions in biopharma and drug delivery sectors.
Strategic Advisory Services
Provides strategic advice and scientific direction for biopharma R&D from discovery to early clinical development stages.
Interim Management
Offers temporary operational and executive management support to supplement or lead R&D teams in biotech startups and companies.
Technology Diligence
Conducts technical due diligence to support venture investment, licensing, and mergers and acquisitions in biopharma and drug delivery sectors.
Services
Strategic and scientific advisory for discovery through early clinical development, including program strategy, technical review, and scientific direction.
Strategic and scientific advisory for discovery through early clinical development, including program strategy, technical review, and scientific direction.
Expertise Areas
- Preclinical program development and prioritization
- Early clinical development planning
- Nanomedicine and drug delivery
- RNA therapeutics and RNA biology
Key Technologies
- Nanotechnology for therapeutics
- Targeted drug delivery
- RNA therapeutics
- Drug delivery systems
News & Updates
Conference focusing on nanotechnology and related scientific topics held in Krems, Austria.
Partnering and investor conference held in Boston, MA.
Symposium on RNA biology and therapeutic implications held at the Koch Institute (MIT) in Cambridge, MA.
Conference on RNA and peptide therapeutics held in Providence, RI.
RNA Society conference held in Quebec covering RNA and peptide science.
American Society of Gene & Cell Therapy conference held in Washington, DC.
Conference focusing on nanotechnology and related scientific topics held in Krems, Austria.
Partnering and investor conference held in Boston, MA.
Symposium on RNA biology and therapeutic implications held at the Koch Institute (MIT) in Cambridge, MA.
Conference on RNA and peptide therapeutics held in Providence, RI.
RNA Society conference held in Quebec covering RNA and peptide science.
American Society of Gene & Cell Therapy conference held in Washington, DC.